Shota Yoshida

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Ischemia Reperfusion Injury

High Fat Diet Induced

Inflammatory Response

Subarachnoid Hemorrhage

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Munehisa Shimamura, Hiroki Hayashi, Nan Ju, Shota Yoshida, Satoshi Baba, Tsutomu Sasaki, Hideki Mochizuki, Ryuichi Morishita, Hironori Nakagami
R-spondin 3/LGR4 (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4) Axis Is a Novel Inflammatory and Neurite Outgrowth Signaling System in the Ischemic Brain in Mice. Stroke (2023)
Munehisa Shimamura, Hiroki Hayashi, Nan Ju, Shota Yoshida, Satoshi Baba, Tsutomu Sasaki, Hideki Mochizuki, Ryuichi Morishita, Hironori Nakagami
R-spondin 3/LGR4 (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4) Axis Is a Novel Inflammatory and Neurite Outgrowth Signaling System in the Ischemic Brain in Mice. Stroke 54 (6) (2023)
Nan Ju, Hiroki Hayashi, Munehisa Shimamura, Shota Yoshida, Ryo Nakamaru, Hironori Nakagami, Ryuichi Morishita, Hiromi Rakugi
Prevention of Acute Lung Injury by a Novel CD14-Inhibitory Receptor Activator of the NF-κB Ligand Peptide in Mice. ImmunoHorizons 5 (6) (2021)
Shota Yoshida, Hironori Nakagami, Hiroki Hayashi, Yuka Ikeda, Jiao Sun, Akiko Tenma, Hideki Tomioka, Tomohiro Kawano, Munehisa Shimamura, Ryuichi Morishita, Hiromi Rakugi
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nature communications 11 (1) (2020)